Search results
Stem cell transplants and survival rates on the rise across all racial and ethnic groups
Medical Xpress· 6 days agoThe volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster...
Computational modeling reveals key factors driving treatment-free remission in chronic myeloid ...
Nature· 4 days agoPatients with chronic myeloid leukemia (CML) who receive tyrosine kinase inhibitors (TKIs) have been known to achieve treatment-free remission (TFR) upon discontinuing treatment ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 7 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue
Medscape· 7 days agoAre you familiar with the presentation, workup, treatment, and monitoring of CML? Dr Adam Braun provides a brief guide.
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Newswise· 7 days agoBy studying EP300 and CBP, critical proteins in Group 3 medulloblastoma cells, scientists at St....
Study highlights increased risk of second cancers among breast cancer survivors
Medical Xpress· 7 days agoSurvivors of breast cancer are at significantly higher risk of developing second cancers, including...
Cancer survivors from poorer places at higher risk of second cancer
KTBS Shreveport· 6 days agoBreast cancer survivors from more deprived areas are at a far higher risk of developing a second...
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
FOX 59 Indianapolis· 7 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at the American Society of Clinical Oncology (ASCO) ...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 day agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...